Leadership Overview
Contract Pharmacal has 4 executives leading key functions including finance, operations, human resources, and executive leadership.
Driven by a commitment to quality, Contract Pharmacal manufactures and packages pharmaceuticals, over-the-counter drugs, and dietary supplements for a global clientele, impacting health and wellness worldwide.
Driven by a commitment to quality, Contract Pharmacal manufactures and packages pharmaceuticals, over-the-counter drugs, and dietary supplements for a global clientele, impacting health and wellness worldwide.
Leadership Roles at Contract Pharmacal
Eric Antman - Chief Financial Officer
Eric Antman, the Chief Financial Officer at Contract Pharmacal, directs all financial strategy and fiscal operations. Overseeing budgeting, forecasting, and financial reporting, Antman ensures robust financial health and compliance across the organization. This leadership role involves managing capital allocation, optimizing investment strategies, and securing funding to support Contract Pharmacal's manufacturing and packaging initiatives for pharmaceuticals, over-the-counter drugs, and dietary supplements. By analyzing market trends and economic conditions, Eric Antman drives financial planning to support global distribution and operational scaling. His expertise is critical in maintaining profitability and enabling strategic growth for the company's diverse product lines, ensuring sustained financial stability and shareholder value.
Jeffrey Reingold - Chief Operating Officer
Jeffrey Reingold, the Chief Operating Officer at Contract Pharmacal, orchestrates all manufacturing and operational processes. Reingold oversees the end-to-end production lifecycle, from raw material sourcing to final product packaging, ensuring adherence to stringent quality standards for pharmaceuticals, over-the-counter drugs, and dietary supplements. This executive position involves optimizing supply chain logistics, enhancing production efficiency, and implementing advanced manufacturing technologies to meet global demand. By driving operational excellence, Jeffrey Reingold ensures seamless execution of contracts with pharmaceutical companies, retailers, and wholesalers worldwide. His focus on operational integrity directly supports Contract Pharmacal's mission to deliver high-quality products consistently and reliably, underpinning the company's reputation for dependable manufacturing.
Mark Wolf - President
Mark Wolf, the President at Contract Pharmacal, provides overarching executive direction and strategic vision for the company. Wolf guides the organization's growth initiatives, market positioning, and long-term objectives, ensuring alignment across all functional areas. This leadership role involves fostering key relationships with clients, partners, and stakeholders, driving business development and expanding Contract Pharmacal's global footprint in pharmaceutical, over-the-counter drug, and dietary supplement manufacturing and packaging. By championing innovation and operational excellence, Mark Wolf steers the company towards sustained success and market leadership. His comprehensive oversight ensures the continued delivery of high-quality products and services to a worldwide customer base.
Robyn Wolf-Eagle - Chief Human Resources Officer
Robyn Wolf-Eagle, the Chief Human Resources Officer at Contract Pharmacal, leads all human capital strategies and organizational development. Wolf-Eagle oversees talent acquisition, employee relations, compensation, and benefits programs, fostering a productive and compliant work environment. This critical role involves developing and implementing HR policies that support the company's manufacturing and packaging operations for pharmaceuticals, over-the-counter drugs, and dietary supplements. By cultivating a strong organizational culture and ensuring employee engagement, Robyn Wolf-Eagle drives workforce performance and retention. Her strategic direction is essential for aligning human resources with Contract Pharmacal's business objectives, supporting its global reach and commitment to quality manufacturing.
Explore Leadership Teams in Manufacturing
PharmaLogic Holdings Corp. is a global contract development and manufacturing organization (CDMO) specializing in diagnostic and therapeutic radiopharmaceuticals. Through a network of radiopharmacies and manufacturing facilities across North America and Europe, it develops, manufactures, and distributes clinical and commercial radiopharmaceutical products to pharmaceutical partners and healthcare providers.
Company Leadership
HP
GP
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Company Leadership SG
JB
EL
OPKO Health, Inc. is a fully integrated, diversified healthcare company founded in 2006 and headquartered in Miami, Florida. The company operates across two primary segments Pharmaceuticals and Diagnostics engaged in the discovery, development, and commercialization of medicines and diagnostic testing services for serious diseases. Its diagnostics operations include a large clinical reference laboratory offering a broad range of testing services spanning molecular diagnostics, genetics, anatomical pathology, and women's health. Its pharmaceutical operations focus on developing and commercializing treatments across endocrinology and other therapeutic areas, as well as advancing multispecific antibody therapies for oncology and infectious disease through its biotechnology subsidiary. OPKO Health operates across the United States and internationally, with established pharmaceutical platforms in multiple countries. The company trades on the NASDAQ under the ticker symbol OPK.
Company Leadership
CB
AK
Biophore specializes in the development and manufacturing of niche pharmaceutical products, focusing on APIs and intermediates for the global pharmaceutical industry. The company aims to enable its clients to reach the market quickly, ensuring faster access to patients. With a diverse product range and expertise in complex chemistry, Biophore is a trusted partner for collaborative projects. Their operations are supported by US FDA and EU approved manufacturing facilities, emphasizing quality and innovation.
Company Leadership KK
SA
RL
Frequently Asked Questions Regarding Contract Pharmacal Top Executives and Leadership Team
